Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Telmisartan and Ramipril Alone and in Combination
NCT02215005Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2007
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial in hypertension (HTN) comparing Telmisartan + Ramipril, Telmisartan and Ramipril (3 arms). Primary endpoints: Area Under the Curve at Steady State (AUCtau,ss) and Maximum Plasma Concentration at Steady State (Cmax,ss). Started Jun 2007; status: completed.
02
Drugs
telmisartanramipril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02215005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215005.